
Johnson & Johnson
JNJ 260.35 (-0.66%) 1.72
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $627.42(B)
EV: $655.70(B)
Total Equity: $84.97(B)
Earnings date: Oct-13-2026
P/E: 29.79
Forward P/E: 23.56
P/FCF: 28.18
P/S: 6.40
P/B: 7.38
EPS: $8.7
EPS (fwd): $11.1
FCF/share: $9.2
Revenue/share: $40.7
Book value/share: $35.3
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.58
Current Ratio: 1.10
Gross margin: 68.1%
Operating margin: 26.2%
Net margin: 21.5%
Dividend/share: $5.2
Div. yield: 2.01%
